Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis. - Wikidata - thesis-toulmin - TriplyDB

Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis.

Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis.

http://www.wikidata.org/entity/Q35768564

about

Anti-MrkA Monoclonal Antibodies Reveal Distinct Structural and Antigenic Features of MrkA.Autoantibody-Mediated Pulmonary Alveolar Proteinosis in Rasgrp1-Deficient Mice.Loss of immune tolerance to IL-2 in type 1 diabetes.Targeting GM-CSF in inflammatory diseases.Ro52 autoantibodies arise from self-reactive progenitors in a mother of a child with neonatal lupus.Public antibodies to malaria antigens generated by two LAIR1 insertion modalities.Disseminated Cryptococcosis Due to Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Absence of Pulmonary Alveolar Proteinosis.Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease.A novel antibody discovery platform identifies anti-influenza A broadly neutralizing antibodies from human memory B cells.Pulmonary pharmacodynamics of an anti-GM-CSFRα antibody enables therapeutic dosing that limits exposure in the lung.AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease.Dissecting human antibody responses: useful, basic and surprising findings.Investigational therapies targeting the granulocyte macrophage colony-stimulating factor receptor-α in rheumatoid arthritis: focus on mavrilimumab.Rituximab for auto-immune alveolar proteinosis, a real life cohort study.

P2860

Q36255651-3A0F85B9-0EAB-45E1-B0BF-F8A29458647A Q37072048-8334FE66-7F8B-4AAB-9EFE-C3BD2F7E2298 Q37330454-03D273AC-D79C-406F-BAC8-76977F6AB064 Q38657999-913DB38A-A9F0-4E4F-9C27-C2D7B139A882 Q39001406-ADCEFC53-E3F7-4789-9C55-8E24D48395E2 Q39355640-CA8D4E4E-F535-4730-A722-FD7DEDB8ED2E Q40396098-CE04358E-3C20-43EA-9298-21EFAF0B1AFF Q40575597-029C71F1-8AF0-45C7-9492-55DC0CDA73C3 Q40726829-310148C6-A507-4A55-A8C7-F64CA0F8A456 Q41416064-80F03DE4-9803-4DCF-8C8A-DBF2CDE3A03F Q41819064-249B92FD-44CA-4055-BDF7-C4CCA759373B Q42225256-AE53B8AC-C2B1-48C7-B18B-2F826FF6B0E8 Q48023106-D41AC556-79CC-4D9E-AA67-6CCBC2DE5521 Q49393096-ECE4D4A5-D9F6-4EF7-9958-5F496145C95A Q55239888-694003FD-E242-46A4-ACBA-03C9CC8B73D4

P2860

Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis.

http://www.wikidata.org/entity/Q35768564

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Neutralization and clearance o ...... ulmonary alveolar proteinosis.

@ast

Neutralization and clearance o ...... ulmonary alveolar proteinosis.

@en

type

label

Neutralization and clearance o ...... ulmonary alveolar proteinosis.

@ast

Neutralization and clearance o ...... ulmonary alveolar proteinosis.

@en

prefLabel

Neutralization and clearance o ...... ulmonary alveolar proteinosis.

@ast

Neutralization and clearance o ...... ulmonary alveolar proteinosis.

@en

P1433

Q35768564-9DB27A51-4423-437E-B6F4-7A92CFB6A635

P1476

Q35768564-EE0C1052-BC86-4774-9E2C-84AFBA3F54C7

P2093

Q35768564-23BA1506-97C4-49B8-9EFA-1D954146A340

Q35768564-43B2E112-AD53-451B-BE04-F857ECC1DE9F

Q35768564-453182DE-6519-40E9-AE36-19A47513DD22

Q35768564-55E46A8F-58AB-4DB5-AD09-DC017603B2B4

Q35768564-81BC638C-048A-4074-95EC-48445454ACF3

Q35768564-ABE6BD73-472C-469B-A459-CE3D9A1118F2

Q35768564-E13A7A74-CFAF-4FE4-8814-7074150E2F4F

P2860

Q35768564-0065DB73-ADE4-4CA0-9CF5-D4BD6A41150C

Q35768564-02B49427-C2B5-452A-BD7F-C37F7A044670

Q35768564-07C68B6E-A53F-4BA1-861B-6AFE10B7D0EA

Q35768564-0874C177-42B4-47BB-8F54-8ECA6897FF8C

Q35768564-0E3EEA24-BFDF-4225-BA52-B4A0B605F845

Q35768564-0F9FC203-8C67-4F7F-A0DD-BAAFA23C97BE

Q35768564-1ED0361E-1879-41BD-9324-0BAB6402EC75

Q35768564-30BD382C-25FF-4406-898A-A088AB1A336B

Q35768564-412E70FF-AA2D-428D-A63D-A2387A5BC2F2

Q35768564-4AE66574-B2F3-4157-ABA7-8A4A1360A8A5

P2888

Q35768564-98411AD8-0F2A-4F65-8C17-046D5694A8D8

P304

Q35768564-6EE3AD8A-BE96-47A5-B4F6-72D7C543BF17

P31

Q35768564-55AB1388-F2BC-4169-96D7-A7AD6E2F5F73

P356

Q35768564-49AFBA01-D0D6-4F0A-830A-5D0A3285CCBD

P407

Q35768564-C4629586-C6A1-4038-8C72-23DA5B8097E2

P478

Q35768564-68DAB3C3-5A44-46F4-9751-783961A66688

P50

Q35768564-0BC642D8-1FB2-469C-A86A-79A9A837195F

Q35768564-79EB53BE-74E7-40E4-B0BC-7A9B28E1B416

P577

Q35768564-24888394-C740-40B6-BE65-172DCAA30747

P5875

Q35768564-F6658E88-C1ED-4EEF-9157-AF29466F4944

P698

Q35768564-7455CF3A-73AE-47F8-A34B-4C47BDD53ED5

P921

Q35768564-8232A2EE-4D3E-44B2-B4F5-1EF502FC9B38

P932

Q35768564-AD6DA8B5-AED4-4A2E-BE5F-B9A677A8047F

P356

P1433

Nature Communications

P1476

Neutralization and clearance o ...... ulmonary alveolar proteinosis.

@en

P2093

Andrea Minola

http://www.w3.org/2001/XMLSchema#string

Blanca Maria Fernandez Rodriguez

http://www.w3.org/2001/XMLSchema#string

Chiara Silacci Fregni

http://www.w3.org/2001/XMLSchema#string

Davide Corti

http://www.w3.org/2001/XMLSchema#string

Ilaria Campo

http://www.w3.org/2001/XMLSchema#string

Luca Piccoli

http://www.w3.org/2001/XMLSchema#string

Maurizio Luisetti

http://www.w3.org/2001/XMLSchema#string

P2860

The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation

Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification.

IMGT, the international ImMunoGeneTics information system.

Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain.

MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial.

P2888

P304

7375

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS8375

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Lanzavecchia

Federica Sallusto

P577

2015-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278732888

http://www.w3.org/2001/XMLSchema#string

P698

26077231

http://www.w3.org/2001/XMLSchema#string

P921

P932

4477037

http://www.w3.org/2001/XMLSchema#string